CIM
CNCE

Cambria Investment Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Cambria Investment Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-15,046
Closed -$223K – 308
2018
Q3 		$223K Buy
15,046
+2,210
+17% +$32.8K 0.03% 273
2018
Q2 		$216K Buy
+12,836
New +$216K 0.03% 275